Previous studies have suggested that iron supplementation, especially in combination with erythropoietin-stimulating agents, may be an effective approach at managing both absolute iron deficiency anemia as well as chemotherapy-induced functional anemia, but these studies did not investigate sex-differences in the context of glioblastoma45,46. Here, EPO is linked to Iron deficiency anemia.